Atnaujinkite slapukų nuostatas

Aging: The Longevity Dividend [Minkštas viršelis]

Edited by , Edited by , Edited by
  • Formatas: Paperback / softback, 256 pages
  • Išleidimo metai: 31-Dec-2015
  • Leidėjas: Cold Spring Harbor Laboratory Press,U.S.
  • ISBN-10: 1621821633
  • ISBN-13: 9781621821632
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 256 pages
  • Išleidimo metai: 31-Dec-2015
  • Leidėjas: Cold Spring Harbor Laboratory Press,U.S.
  • ISBN-10: 1621821633
  • ISBN-13: 9781621821632
Kitos knygos pagal šią temą:
"Aging affects us all and is characterized not only by increasing frailty but by increased susceptibility to conditions such as Alzheimer's, cardiovascular disease, and cancer. We are gaining an increasing understanding of the molecular mechanisms underlying aging, however, and uncovering clues to how life may be prolonged. This book examines the biological basis of aging and research into strategies that may extend lifespan"--

Aging is one of the greatest challenges currently facing society. People are living longer than ever, but many of the later years are fraught with frailty and disease, placing enormous burden on health-care systems. Understanding the biological changes that occur during aging and developing strategies to address them are therefore urgently needed.

Written and edited by experts in the field, this collection from Cold Spring Harbor Perspectives in Medicineexamines the biological basis of aging, strategies that may extend health span, and the societal implications of delayed aging. Contributors discuss genetic variants that accelerate or protect against aging, biochemical pathways that modulate longevity (e.g., mTOR), biological consequences of aging (e.g., decline in stem cell function), and various animal models used to study aging processes. They emphasize that age-delaying interventions will yield greater health and vitality than disease-specific treatments. Drugs that may promote health span or longevity (e.g., metformin) and efforts to prevent and treat frailty (e.g., through exercise) are explored.

The authors consider the socioeconomic benefits and costs of delayed aging and also outline directions for future research and translational efforts. This volume will serve as a vital reference for all involved in the fields of geroscience and geriatric medicine, as well as anyone wishing to understand physiological processes that generate health and disease, regardless of chronological age.
Foreword vii
Janko Nikolich-Zugich
Preface ix
Introduction
The Emergence of Geroscience as an Interdisciplinary Approach to the Enhancement of Health Span and Life Span
1(14)
Felipe Sierra
PART I BASIC MECHANISMS OF BIOLOGICAL AGING
The Role of the Microenvironmental Niche in Declining Stem-Cell Functions Associated with Biological Aging
15(10)
Nathan A. DeCarolis
Elizabeth D. Kirby
Tony Wyss-Coray
Theo D. Palmer
Biochemical Genetic Pathways that Modulate Aging in Multiple Species
25(26)
Alessandro Bitto
Adrienne M. Wang
Christopher F. Bennett
Matt Kaeberlein
DNA Damage, DNA Repair, Aging, and Neurodegeneration
51(18)
Scott Maynard
Evandro Fei Fang
Morten Scheibye-Knudsen
Deborah L. Croteau
Vilhelm A. Bohr
How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative
69(24)
Fuki M. Hisama
Junko Oshima
George M. Martin
Dissecting the Mechanisms Underlying Successful Human Health Span and Life Span
93(14)
Sofiya Milman
Nir Barzilai
The Companion Dog as a Model for the Longevity Dividend
107(14)
Kate E. Creevy
Steven N. Austad
Jessica M. Hoffman
Dan G. O'Neill
Daniel E.L. Promislow
PART II CLINICAL AND TRANSLATIONAL ASPECTS OF AGING
Translating the Science of Aging into Therapeutic Interventions
121(14)
James L. Kirkland
Interventions for Human Frailty: Physical Activity as a Model
135(14)
Linda P. Fried
The Aging Heart
149(16)
Ying Ann Chiao
Peter S. Rabinovitch
Inhibition of the Mechanistic Target of Rapamycin (mTOR)---Rapamycin and Beyond
165(14)
Dudley W. Lamming
Metformin: A Hopeful Promise in the Aging Research
179(12)
Marta G. Novelle
Ahmed Ali
Carlos Dieguez
Michel Bernier
Rafael de Cabo
PART III SOCIETAL IMPLICATIONS OF DELAYED AGING
Articulating the Case for the Longevity Dividend
191(6)
S. Jay Olshansky
The Economic Promise of Delayed Aging
197(12)
Dana Goldman
Past, Present, and Future of Healthy Life Expectancy
209(12)
Hiram Beltran-Sanchez
Samir Soneji
Eileen M. Crimmins
Has the Rate of Human Aging Already Been Modified?
221(18)
S. Jay Olshansky
Index 239